DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.message sent
email sent successfully
| You are receiving this because you have an account on www.oneGRAVESvoice.com | ||
| To unsubscribe from these emails, click here |
Trusted Resources: News & Meetings
Latest announcements and gatherings
Radioactive Iodine Can Be First-Line for Hyperthyroidism, Says UK
New UK guidelines for the treatment of hyperthyroidism, including Graves’ disease, place heavier emphasis on the use of radioactive iodine as the frontline treatment for patients unlikely to remain remission-free on the medications, as opposed to the alternative of antithyroid medications as a first choice.
“Our evidence reviews indicated that radioactive iodine is the most clinically and cost-effective treatment for hyperthyroidism,” senior author Kristien Boelaert, MD, PhD, who led the guideline committee, told Medscape Medical News.
“Recommending the use of radioactive iodine as first-line treatment for adults with Graves’ disease is a change to current practice and should reduce the variation between centers as to when radioactive iodine is considered appropriate,” the guidelines further state.
myBinderRelated Content
-
Evidence & EducationIncreased Cardiovascular Mortality and Morbidity in Patients Treated for Toxic Nodular Goiter Compared to GravesR...Background: Previous research has sugge...
-
Evidence & EducationNational Trends in Incidence, Mortality, and Clinical Outcomes of Patients Hospitalized for Thyrotoxicosis With and ...Background: Current evidence on the i...
-
News & MeetingsEarly, Effective Control of Graves’ Disease Improves Survival, Regardless of TreatmentAn early and intensive control of hypert...
-
Evidence & EducationThe Efficacy of Rituximab Combined with 131I for Ophthalmic Outcomes of Graves’ Ophthalmopathy PatientsPurpose: The purpose of this study is t...
-
Evidence & EducationSubclinical Hypothyroidism After 131I-Treatment of Graves’ Disease: A Risk Factor for Depression?Objectives: Although it is well accepte...
-
Evidence & EducationThyroid-Associated Ophthalmopathy After Treatment for Graves’ Hyperthyroidism With Antithyroid Drugs or Iodine...Context: Previous randomized trials hav...
-
Evidence & Education131I-Induced Graves’ Disease in Patients Treated for Toxic Multinodular Goitre: Systematic Review and Descript...Background: Graves’ disease (GD) aris...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.